Kaya Serdar, Lam Fred C, Stevenson Mary Ann, Motiei-Langroudi Rouzbeh, Kasper Ekkehard M
Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA 02115, USA.
Department of Neurosurgery, St. Elizabeth's Medical Center, Boston, MA 02135, USA.
Brain Sci. 2024 Jul 29;14(8):761. doi: 10.3390/brainsci14080761.
Intramedullary metastases to the conus medullaris spinalis (IMCM) pose a rare problem in neurosurgical oncology and are usually encountered as a complicated clinical scenario in the setting of advanced systemic malignancy with poor overall survival. Despite the progress in interdisciplinary oncological care, their management remains complicated. We performed a PRISMA-guided literature search to achieve a pooled analysis of all previously reported IMCM cases that contained detailed clinical data on this problem to investigate the currently employed management options and respective outcomes. We obtained a clinical vignette and performed a comprehensive narrative review of IMCM management. The PubMed/MEDLINE/Google Scholar, Cochrane and Embase databases were systematically searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. All relevant publications retrieved were subjected to full-text analysis in detail and pertinent information was extracted. The most common systemic primary tumor site as the origin of IMCM was the lung, followed by the breast. Overall, the pooled median survival was 6 months (range 0.5-36 months). Patients who received both surgery and radiation therapy had the longest overall survival (OS) (mean 9.9 months) and those who received no oncological treatment (neither surgery nor adjuvant therapy) had the shortest OS (mean 3.6 months). In cases where surgical resection was performed as part of the treatment plan for metastases, those with partial tumor resection had a more favorable neurological outcome than patients who underwent aggressive gross total resection. Based on the results of our analysis, we find that diligent microsurgical resection (subtotal or total) followed by radiation therapy appears as an effective and suitable treatment in select patients with IMCM. When surgery is not feasible as part of the treatment algorithm, radiation therapy alone (conventional or radiosurgery) also appears to be a suitable treatment option that confers a benefit to the patient.
脊髓圆锥髓内转移瘤(IMCM)在神经外科肿瘤学中是一个罕见问题,通常在晚期全身恶性肿瘤且总体生存率较低的复杂临床情况下出现。尽管跨学科肿瘤护理取得了进展,但其管理仍然复杂。我们进行了一项遵循PRISMA指南的文献检索,以对所有先前报道的包含该问题详细临床数据的IMCM病例进行汇总分析,以研究当前采用的管理方案和各自的结果。我们获取了一个临床案例并对IMCM管理进行了全面的叙述性综述。根据系统评价和Meta分析的首选报告项目(PRISMA)指南,系统检索了PubMed/MEDLINE/谷歌学术、Cochrane和Embase数据库。对检索到的所有相关出版物进行详细的全文分析,并提取相关信息。作为IMCM起源的最常见全身原发性肿瘤部位是肺,其次是乳腺。总体而言,汇总的中位生存期为6个月(范围0.5 - 36个月)。接受手术和放射治疗的患者总体生存期(OS)最长(平均9.9个月),而未接受任何肿瘤治疗(既未手术也未接受辅助治疗)的患者OS最短(平均3.6个月)。在将手术切除作为转移瘤治疗计划一部分的病例中,部分肿瘤切除的患者神经功能结果比接受积极全切的患者更有利。根据我们的分析结果,我们发现对于部分选择的IMCM患者,勤勉的显微手术切除(次全或全切)后进行放射治疗似乎是一种有效且合适的治疗方法。当手术作为治疗方案不可行时,单纯放射治疗(传统放疗或立体定向放射外科治疗)似乎也是一种能使患者获益的合适治疗选择。